JO
BBP icon

John Overdeck’s Virtus Biotech ETF BBP Stock Holding History

John Overdeck’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
17,000
+6,000
+55% +$522K ﹤0.01% 3177
2026
Q1 		$914K Hold
11,000
– – ﹤0.01% 3328
2025
Q4 		$879K Buy
+11,000
New +$835K ﹤0.01% 3012

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

John Overdeck's BBP Position: Q2 2026 in Review

John Overdeck increased its Virtus Biotech ETF (BBP) stake by 55% in Q2 2026, buying an estimated $522K and bringing the position to 17,000 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

John Overdeck first reported a position in BBP in Q4 2025 and has held it in 3 quarters since. 25 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • John Overdeck held 17,000 shares of Virtus Biotech ETF worth $1.64M as of Q2 2026.
  • John Overdeck bought 6,000 Virtus Biotech ETF shares in Q2 2026, an estimated $522K.
  • Virtus Biotech ETF made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3177 holding.
  • John Overdeck first reported a position in Virtus Biotech ETF in Q4 2025 and has held it in 3 quarters since.
  • 25 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.